BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34994834)

  • 1. Accurate Nodal Staging in Pancreatic Cancer in the Era of Neoadjuvant Therapy.
    Javed AA; Ding D; Baig E; Wright MJ; Teinor JA; Mansoor D; Thompson E; Hruban RH; Narang A; Burns WR; Burkhart RA; Lafaro K; Weiss MJ; Cameron JL; Wolfgang CL; He J
    World J Surg; 2022 Mar; 46(3):667-677. PubMed ID: 34994834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reappraisal of nodal staging and study of lymph node station involvement in distal pancreatectomy for body-tail pancreatic ductal adenocarcinoma.
    Malleo G; Maggino L; Nobile S; Casciani F; Cacciatori N; Paiella S; Luchini C; Rusev B; Capelli P; Marchegiani G; Bassi C; Salvia R
    Eur J Surg Oncol; 2020 Sep; 46(9):1734-1741. PubMed ID: 32327367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reassessment of the Optimal Number of Examined Lymph Nodes in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma.
    Malleo G; Maggino L; Qadan M; Marchegiani G; Ferrone CR; Paiella S; Luchini C; Mino-Kenudson M; Capelli P; Scarpa A; Lillemoe KD; Bassi C; Castillo CF; Salvia R
    Ann Surg; 2022 Nov; 276(5):e518-e526. PubMed ID: 33177357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymph node examination and survival in resected pancreatic ductal adenocarcinoma: retrospective study.
    Goess R; Jäger C; Perinel J; Pergolini I; Demir E; Safak O; Scheufele F; Schorn S; Muckenhuber A; Adham M; Novotny A; Ceyhan GO; Friess H; Demir IE
    BJS Open; 2024 Jan; 8(1):. PubMed ID: 38271272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Number of Examined Lymph Nodes and Nodal Status Assessment in Distal Pancreatectomy for Body/Tail Ductal Adenocarcinoma.
    Malleo G; Maggino L; Ferrone CR; Marchegiani G; Mino-Kenudson M; Capelli P; Rusev B; Lillemoe KD; Bassi C; Fernàndez-Del Castillo C; Salvia R
    Ann Surg; 2019 Dec; 270(6):1138-1146. PubMed ID: 29672406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of para-aortic lymph node status in resected pancreatic ductal adenocarcinoma and invasive intraductal papillary mucinous neoplasm - Time to consider a reclassification?
    Linder S; Holmberg M; Engstrand J; Ghorbani P; Sparrelid E
    Surg Oncol; 2022 May; 41():101735. PubMed ID: 35287096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total Neoadjuvant Treatment for Pancreatic Ductal Adenocarcinoma Is Associated With Limited Lymph Node Yield but Improved Ratio.
    Barrak D; Villano AM; Moslim MA; Hopkins SE; Lefton MD; Ruth K; Reddy SS
    J Surg Res; 2022 Dec; 280():543-550. PubMed ID: 36096019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining a minimum number of examined lymph nodes improves the prognostic value of lymphadenectomy in pancreas ductal adenocarcinoma.
    Pu N; Gao S; Beckman R; Ding D; Wright M; Chen Z; Zhu Y; Hu H; Yin L; Beckman M; Thompson E; Hruban RH; Cameron JL; Gage MM; Lafaro KJ; Burns WR; Wolfgang CL; He J; Yu J; Burkhart RA
    HPB (Oxford); 2021 Apr; 23(4):575-586. PubMed ID: 32900612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of Examined Lymph Node Number in Accurate Staging and Long-term Survival in Resected Stage I-II Pancreatic Cancer-More is Better? A Large International Population-based Cohort Study.
    Huang L; Jansen L; Balavarca Y; van der Geest L; Lemmens V; Koerkamp BG; van Santvoort HC; Grützmann R; Besselink MG; Schrotz-King P; Brenner H
    Ann Surg; 2021 Dec; 274(6):e554-e563. PubMed ID: 31425290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic adenocarcinoma: number of positive nodes allows to distinguish several N categories.
    Strobel O; Hinz U; Gluth A; Hank T; Hackert T; Bergmann F; Werner J; Büchler MW
    Ann Surg; 2015 May; 261(5):961-9. PubMed ID: 24979603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of nodal statuses in patients with pancreatic ductal adenocarcinoma.
    Fukuda Y; Asaoka T; Maeda S; Hama N; Miyamoto A; Mori M; Doki Y; Nakamori S
    Pancreatology; 2017; 17(2):279-284. PubMed ID: 28122676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gross tumor size using the AJCC 8th ed. T staging criteria does not provide prognostic stratification for neoadjuvant treated pancreatic ductal adenocarcinoma.
    Rowan DJ; Hartley CP; Aldakkak M; Christians KK; Evans DB; Tsai S; Hagen CE
    Ann Diagn Pathol; 2020 Jun; 46():151485. PubMed ID: 32172219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nodal downstaging as a treatment goal for node-positive pancreatic cancer.
    Portuondo JI; Massarweh NN; Zhang Q; Chai CY; Tran Cao HS
    Surgery; 2019 Jun; 165(6):1144-1150. PubMed ID: 30745009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic ductal adenocarcinoma (PDAC) regional nodal disease at standard lymphadenectomy: is MRI accurate for identifying node-positive patients?
    Adham S; Ferri M; Lee SY; Larocque N; Alwahbi OA; Ruo L; van der Pol CB
    Eur Radiol; 2023 Sep; 33(9):5976-5983. PubMed ID: 37004569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determining the optimal number of examined lymph nodes for accurate staging of pancreatic cancer: An analysis using the nodal staging score model.
    Hua J; Zhang B; Xu J; Liu J; Ni Q; He J; Zheng L; Yu X; Shi S
    Eur J Surg Oncol; 2019 Jun; 45(6):1069-1076. PubMed ID: 30685327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AJCC 8th edition pathologic nodal staging of resected pancreatic adenocarcinoma predicts survival regardless of treatment sequencing.
    Oppliger FA; Prakash LR; Newhook TE; Chiang YJ; Ikoma N; Maxwell JE; Kim MP; Vauthey JN; Lee JE; Katz MH; Tzeng CD
    Surg Oncol; 2022 Mar; 40():101673. PubMed ID: 34894620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant therapy is associated with a reduced lymph node ratio in patients with potentially resectable pancreatic cancer.
    Roland CL; Yang AD; Katz MH; Chatterjee D; Wang H; Lin H; Vauthey JN; Pisters PW; Varadhachary GR; Wolff RA; Crane CH; Lee JE; Fleming JB
    Ann Surg Oncol; 2015 Apr; 22(4):1168-75. PubMed ID: 25352267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical Decision-Making in Pancreatic Ductal Adenocarcinoma: Modeling Prognosis Following Pancreatectomy in the Era of Induction and Neoadjuvant Chemotherapy.
    Habib JR; Kinny-Köster B; Bou-Samra P; Alsaad R; Sereni E; Javed AA; Ding D; Cameron JL; Lafaro KJ; Burns WR; He J; Yu J; Wolfgang CL; Burkhart RA
    Ann Surg; 2023 Jan; 277(1):151-158. PubMed ID: 33843794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Criterion for Lymph Nodes Dissection in Distal Pancreatectomy for Ductal Adenocarcinoma: A Population Study of the US SEER Database.
    Wang W; Shen Z; Zhang J; Chen H; Deng X; Peng C; Xie J; Xu Z; Shen B
    Ann Surg Oncol; 2022 Mar; 29(3):1533-1539. PubMed ID: 34622372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of Nodal Metastases Location in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: Results from a Prospective, Lymphadenectomy Protocol.
    Malleo G; Maggino L; Casciani F; Lionetto G; Nobile S; Lazzarin G; Paiella S; Esposito A; Capelli P; Luchini C; Scarpa A; Bassi C; Salvia R
    Ann Surg Oncol; 2022 Jun; 29(6):3477-3488. PubMed ID: 35192154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.